SIGN UP
LOG IN
News
Ambio Pharmaceuticals
--
--
0.00%
About Ambio Pharmaceuticals
我们是全球肽CDMO的领导者,在业内主要CDMO中增长最快。我们可在全球提供任何规模且具成本与质量优势的肽类产品。根据弗若斯特沙利文的资料,按 2020年的收益计,我们是全球第四大规模的肽CDMO服务提供商,往绩记录期内按 26.5%的复合年增长率增长。凭藉我们纵向一体化的肽开发及生产能力,我们已提供涵盖临床及商业化阶段的研究、原料药生产、药品开发等全方位综合服务,使我们能够成为理想的肽生产商或肽类药物研发合作伙伴,为全球客户提供灵活及订制化的解决方案。我们为研究新型肽类药物、开发各种肽类产品的大学、生物技术公司以及大型制药公司提供全方位的 CDMO服务,按高质量标准并以业内部分最低成本生产产品。
MoreRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.